Pathology/Lab Coding Alert

Know the Lab Tests Affected

"The new national coverage decisions will impact reimbursement for 65 CPT Codes , which account for approximately 60 percent of laboratory claims, according to the negotiated rulemaking committee that authored the rule," says Laurie Castillo, MA, CPC, CPC-H, CCS-P, member of the national advisory board of the American Academy of Professional Coders (AAPC) and president of Physician Coding and Compliance Consulting in Manassas, Va. The committee which included representatives from CMS and 18 other organizations whose interests may be affected by the rule acted in response to a federal government mandate under the Balanced Budget Act of 1997. The title of each of the 23 policies and the affected CPT codes are listed below:

 

Urine Bacterial Culture 87086, 87088, 87184, 87186
Human Immunodeficiency Virus Testing (Prognosis and Monitoring) 87536, 87539
Human Immunodeficiency Virus Testing (Diagnosis) 86689, 86701, 86702, 86703, 87390, 87391, 87534, 87535, 87537, 87538
Blood Counts (CBC) 85007, 85008, 85013, 85014, 85018, 85021, 85022, 85023, 85024, 85027, 85031, 85048, 85590, 85595
Partial Thromboplastin Time (PTT) 85730
Prothrombin Time (PT) 85610
Serum Iron Studies 82728, 83540, 83550, 84466
Collagen Crosslinks 82523
Blood Glucose Testing 82947, 82948, 82962
Glycated Hemoglobin/Glycated Protein 82985, 83036
Thyroid Testing 84436, 84439, 84443, 84479
Lipids 80061, 82465, 83715, 83716, 83718, 83721,84478
Digoxin Therapeutic Drug Assay 80162
Alpha-fetoprotein (Afp) 82105
Carcinoembryonic Antigen (CEA) 82378
Human Chorionic Gonadotropin (hCG) 84702
Tumor Antigen by Immunoassay for CA 125 86304
Tumor Antigen by Immunoassay for CA 15-3/CA 27.29

86300

Tumor Antigen by Immunoassay for CA 19-9 86301
Prostate Specific Antigen (Total PSA) 84153
Gamma Glutamyltransferase (GGT) 82977
Hepatitis Panel 80074
Fecal Occult Blood 82270.